IMPLEMENTATION OF THE K-EPSILON (K–Ε) MODEL FOR THE SIMULATION OF COAL GASIFIER /REACTOR
Nigerian Journal of Tropical Engineering · 2023
DOI: 10.59081/njte.17.1.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nigerian Journal of Tropical Engineering, 2023. Verfasst von E. G. Ede und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The objective of the present research is to use the standard turbulent kinetic energy and turbulent dissipation (k-e) model to do a numerical modelling and simulation of the gasification chamber or reactor which was used to gasifier Lafia-Obi bituminous coal. The numerical modelling and simulation were implemented with the aid of AutoCAD and Ansys softwares. The gasifier/reactor geometry was modelled using AutoCAD and then imported to Ansys workbench for simulation. Results show the modelled reactor geometry comprising a height of 0.9m, diameter of 0.5m and volume of 0.177m 3 . Simulation results show mass fraction of producer gas components comprising of 16% carbon monoxide, 14% hydrogen, 2.7% methane and 18% carbon dioxide. The producer gas yield is in conformity with standard producer gas yield. Temperature profile around the modelled gasifier/reactor was displayed with a maximum of 960K.
Zitieren
APA
Ede, E. G., Bildad, D. L., Abur, T. B., & Datau, N. (2023). IMPLEMENTATION OF THE K-EPSILON (K–Ε) MODEL FOR THE SIMULATION OF COAL GASIFIER /REACTOR. Nigerian Journal of Tropical Engineering. https://doi.org/10.59081/njte.17.1.003
Vancouver
Ede EG, Bildad DL, Abur TB, Datau N. IMPLEMENTATION OF THE K-EPSILON (K–Ε) MODEL FOR THE SIMULATION OF COAL GASIFIER /REACTOR. Nigerian Journal of Tropical Engineering. 2023. doi:10.59081/njte.17.1.003
BibTeX
@article{Ede2023,
author = {Ede, E. G. and Bildad, D. L. and Abur, T. B. and Datau, N.},
title = {IMPLEMENTATION OF THE K-EPSILON (K–Ε) MODEL FOR THE SIMULATION OF COAL GASIFIER /REACTOR},
journal = {Nigerian Journal of Tropical Engineering},
year = {2023},
doi = {10.59081/njte.17.1.003}
}
EUVIMED